Triglyceride catabolic process

pathway activity — cross-omics
GO:0019433Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Triglyceride catabolic process pathway is significantly associated with the RNA expression of multiple genes, with the GBM cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are CD33, FOLR2, and CD1C, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Triglyceride catabolic process activity versus CD33 in GBM (Pearson r = 0.17).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMCD33 →+0.495+0.157.008.00535
GBMFOLR2 →+1.361+0.248.001<.00135
HNSCCD1C →+0.630+0.166.001<.00135
LUADGPR68 →+0.630+0.223.001<.00135
HNSCMFNG →+0.712+0.182<.001.00234
GBMLY86 →+0.873+0.231<.001<.00134
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0019433 vs CD33 — GBM

Per-sample scatter of Triglyceride catabolic process activity vs CD33 in GBM.

Explore this scatter interactively →

Exploration